One of the listed companies, Indo-Bangla Pharmaceuticals Limited discloses its financial reports for the first quarter, (January – March 24).
The company’s earnings per share (EPS) was loss Tk 0.08 paisa in Q1 of the current financial year (January – March 24). EPS was Tk 0.01 paisa during the same period last year. As of March 31, 2024, at the end of the first quarter of the fiscal year, the company’s net asset value (NAV) per share stood at Tk 13.83.
Share this
